| FXR is a molecular target for the effects of vertical sleeve gastrectomy KK Ryan, V Tremaroli, C Clemmensen, P Kovatcheva-Datchary, ... Nature 509 (7499), 183-188, 2014 | 1000 | 2014 |
| NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON … MB Vos, SH Abrams, SE Barlow, S Caprio, SR Daniels, R Kohli, ... Journal of pediatric gastroenterology and nutrition 64 (2), 319-334, 2017 | 864 | 2017 |
| High‐fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis R Kohli, M Kirby, SA Xanthakos, S Softic, AE Feldstein, V Saxena, ... Hepatology 52 (3), 934-944, 2010 | 436 | 2010 |
| The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids P Puri, K Daita, A Joyce, F Mirshahi, PK Santhekadur, S Cazanave, ... Hepatology 67 (2), 534-548, 2018 | 349 | 2018 |
| Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids R Kohli, D Bradley, KD Setchell, JC Eagon, N Abumrad, S Klein The Journal of Clinical Endocrinology & Metabolism 98 (4), E708-E712, 2013 | 296 | 2013 |
| IL‐17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice ITW Harley, TE Stankiewicz, DA Giles, S Softic, LM Flick, M Cappelletti, ... Hepatology 59 (5), 1830-1839, 2014 | 259 | 2014 |
| Mechanisms of lipotoxicity in NAFLD and clinical implications SH Ibrahim, R Kohli, GJ Gores Journal of pediatric gastroenterology and nutrition 53 (2), 131-140, 2011 | 229 | 2011 |
| Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study C Carter‐Kent, LM Yerian, EM Brunt, P Angulo, R Kohli, SC Ling, ... Hepatology 50 (4), 1113-1120, 2009 | 228 | 2009 |
| Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight‐loss‐independent manner A Myronovych, M Kirby, KK Ryan, W Zhang, P Jha, KDR Setchell, ... Obesity 22 (2), 390-400, 2014 | 196 | 2014 |
| Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats KK Ryan, R Kohli, R Gutierrez-Aguilar, SG Gaitonde, SC Woods, ... Endocrinology 154 (1), 9-15, 2013 | 188 | 2013 |
| Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities R Kohli, M Kirby, KDR Setchell, P Jha, K Klustaitis, LA Woollett, PT Pfluger, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 299 (3 …, 2010 | 178 | 2010 |
| Randomised clinical study: GR‐MD‐02, a galectin‐3 inhibitor, vs. placebo in patients having non‐alcoholic steatohepatitis with advanced fibrosis SA Harrison, SR Marri, N Chalasani, R Kohli, W Aronstein, GA Thompson, ... Alimentary Pharmacology & Therapeutics 44 (11-12), 1183-1198, 2016 | 159 | 2016 |
| Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease SA Xanthakos, DJ Podberesky, SD Serai, L Miles, EC King, WF Balistreri, ... The Journal of pediatrics 164 (1), 186-188, 2014 | 157 | 2014 |
| A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery R Kohli, KDR Setchell, M Kirby, A Myronovych, KK Ryan, SH Ibrahim, ... Endocrinology 154 (7), 2341-2351, 2013 | 148 | 2013 |
| Exposure to per-and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis E Costello, S Rock, N Stratakis, SP Eckel, DI Walker, D Valvi, D Cserbik, ... Environmental health perspectives 130 (4), 046001, 2022 | 140 | 2022 |
| In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores JB Schwimmer, JE Lavine, LA Wilson, BA Neuschwander-Tetri, ... Gastroenterology 151 (6), 1141-1154. e9, 2016 | 133 | 2016 |
| Hepatic natural killer T‐cell and CD8+ T‐cell signatures in mice with nonalcoholic steatohepatitis J Bhattacharjee, M Kirby, S Softic, L Miles, RM Salazar‐Gonzalez, ... Hepatology communications 1 (4), 299-310, 2017 | 126 | 2017 |
| Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children KP Newton, HS Feldman, CD Chambers, L Wilson, C Behling, JM Clark, ... The Journal of pediatrics 187, 141-146. e1, 2017 | 110 | 2017 |
| Society of pediatric liver transplantation: current registry status 2011‐2018 SA Elisofon, JC Magee, VL Ng, SP Horslen, V Fioravanti, J Economides, ... Pediatric transplantation 24 (1), e13605, 2020 | 99 | 2020 |
| The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease S Mansoor, L Yerian, R Kohli, S Xanthakos, P Angulo, S Ling, R Lopez, ... Digestive diseases and sciences 60, 1440-1447, 2015 | 99 | 2015 |
Ariel FeldsteinUCSDVerified email at ucsd.edu
